
United Therapeutics Investor Relations Material
Latest events

Q3 2024
United Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from United Therapeutics Corporation
Access all reports
United Therapeutics Corporation is a biotechnology company specializing in the development and commercialization of therapies to address chronic and life-threatening conditions. The company focuses on treatments for pulmonary arterial hypertension (PAH) and other cardiovascular and respiratory diseases. Its portfolio includes pharmaceutical products and delivery systems designed to improve patient outcomes and quality of life. The company is headquartered in Silver Spring, Maryland, and its shares are listed on the NASDAQ Stock Exchange.
Key slides for United Therapeutics Corporation


43rd Annual J.P. Morgan Healthcare Conference 2025
United Therapeutics Corporation


Q4 2023
United Therapeutics Corporation
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
UTHR
Country
🇺🇸 United States